Good research practices for measuring drug costs in cost-effectiveness analyses: a managed care perspective: the ISPOR Drug Cost Task Force report--Part III (Q84832089)
Jump to navigation
Jump to search
scientific article published on 26 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Good research practices for measuring drug costs in cost-effectiveness analyses: a managed care perspective: the ISPOR Drug Cost Task Force report--Part III |
scientific article published on 26 October 2009 |
Statements
Good research practices for measuring drug costs in cost-effectiveness analyses: a managed care perspective: the ISPOR Drug Cost Task Force report--Part III (English)
Edward C Mansley
Norman V Carroll
Kristina S Chen
Nilay D Shah
Catherine Tak Piech
Joel W Hay
26 October 2009